| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.89B | 33.19B | 29.93B | 28.54B | 30.17B | 32.37B |
| Gross Profit | 5.77B | 5.77B | 5.49B | 4.58B | 4.00B | 6.32B |
| EBITDA | 2.93B | 3.87B | 3.37B | 2.54B | 1.91B | 4.18B |
| Net Income | 1.63B | 1.53B | 1.48B | 820.48M | 310.65M | 2.06B |
Balance Sheet | ||||||
| Total Assets | 30.71B | 30.93B | 30.41B | 29.83B | 31.14B | 32.50B |
| Cash, Cash Equivalents and Short-Term Investments | 1.18B | 1.39B | 1.18B | 972.01M | 853.40M | 718.63M |
| Total Debt | 1.33B | 870.00M | 1.75B | 2.37B | 4.49B | 974.58M |
| Total Liabilities | 12.04B | 11.38B | 11.91B | 12.62B | 14.57B | 15.75B |
| Stockholders Equity | 18.68B | 19.55B | 18.50B | 17.21B | 16.57B | 16.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.14B | 2.97B | 2.50B | -2.84B | -3.37B |
| Operating Cash Flow | 0.00 | 2.06B | 4.37B | 3.63B | 1.48B | -1.33B |
| Investing Cash Flow | 0.00 | -925.00M | -1.42B | -1.14B | -4.34B | -2.08B |
| Financing Cash Flow | 0.00 | -1.22B | -997.00M | -2.39B | 3.00B | -273.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥76.51B | 9.11 | ― | 3.04% | -0.37% | -20.95% | |
71 Outperform | ¥9.34B | 7.23 | ― | 2.84% | 11.35% | -76.94% | |
69 Neutral | ¥16.61B | 9.23 | ― | 3.61% | 6.67% | 66.03% | |
68 Neutral | ¥10.55B | 8.65 | ― | 3.23% | 10.90% | 3.72% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥15.46B | 10.47 | ― | 2.78% | 0.02% | -1.04% |